# Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

> **NCT06269510** · NA · RECRUITING · sponsor: **Henry Ford Health System** · enrollment: 268 (estimated)

## Conditions studied

- Alcohol-related Liver Disease
- Liver Diseases

## Interventions

- **BEHAVIORAL:** ENGAGE-ALD Application (APP)
- **BEHAVIORAL:** Treatment Facilitation bundle
- **BEHAVIORAL:** Enhanced Usual Care

## Key facts

- **NCT ID:** NCT06269510
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2029-08-01
- **Final completion:** 2030-02
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269510, "Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06269510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*